DNA testing can predict which men face the highest risk of deadly prostate cancer, scientists say. The team at the Institute of Cancer Research, in London, say men could soon be offered genetic screening in a similar way to breast cancer in women.
Prostate cancer is the commonest cancer in men in many countries, including the UK – where more than 40,000 people are diagnosed each year.
But not every patient has, or needs, invasive therapy that results in severe side-effects. Identifying which men will need treatment – those who are likely to develop the most aggressive and deadly form of the cancer – is a huge challenge.
Share this article
Read the full, original story: DNA prostate test ‘will predict deadliest cancer risk’
